T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma

Investigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC)...

Full description

Bibliographic Details
Main Authors: Ellen E. Sparger, Hong Chang, Ning Chin, Robert B. Rebhun, Sita S. Withers, Hung Kieu, Robert J. Canter, Arta M. Monjazeb, Michael S. Kent
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2021.772932/full
_version_ 1818570738262605824
author Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
author_facet Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
author_sort Ellen E. Sparger
collection DOAJ
description Investigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC) and baseline tumor samples by flow cytometry, and to compare patient (n = 11–20) T cell phenotypes with healthy controls dogs (n = 10–20). CD3, CD4, CD8, CD25, FoxP3, Ki67, granzyme B, and interferon-γ (IFN-γ) were used to classify T cell subsets in resting and mitogen stimulated PBMCs. In a separate patient cohort (n = 11), T cells were classified using CD3, CD4, CD8, FoxP3, and granzyme B in paired PBMC and single cell suspensions of tumor samples. Analysis of flow cytometric data of individual T cell phenotypes in PBMC revealed specific T cell phenotypes including FoxP3+ and CD25+FoxP3- populations that distinguished patients from healthy controls. Frequencies of IFN-γ+ cells after ConA stimulation identified two different patient phenotypic responses, including a normal/exaggerated IFN-γ response and a lower response suggesting dysfunction. Principle component analysis of selected T cell immunophenotypes also distinguished patients and controls for T cell phenotype and revealed a clustering of patients based on metastasis detected at diagnosis. Findings supported the overall hypothesis that canine melanoma patients display a T cell immunophenotype profile that is unique from healthy pet dogs and will guide future studies designed with larger patient cohorts necessary to further characterize prognostic T cell immunophenotypes.
first_indexed 2024-12-14T13:45:52Z
format Article
id doaj.art-0cfee634520c4c68a85e229019c24a1f
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-14T13:45:52Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-0cfee634520c4c68a85e229019c24a1f2022-12-21T22:59:19ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692021-12-01810.3389/fvets.2021.772932772932T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant MelanomaEllen E. Sparger0Hong Chang1Ning Chin2Robert B. Rebhun3Sita S. Withers4Hung Kieu5Robert J. Canter6Arta M. Monjazeb7Michael S. Kent8Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesCenter for Companion Animal Health, Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesCalifornia National Primate Research Center, Department of Medical Microbiology and Immunology, University of California, Davis, Davis, CA, United StatesCenter for Companion Animal Health, Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesDepartment of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United StatesDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesSurgical Oncology, School of Medicine, University of California, Davis, Sacramento, CA, United StatesRadiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, United StatesCenter for Companion Animal Health, Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesInvestigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC) and baseline tumor samples by flow cytometry, and to compare patient (n = 11–20) T cell phenotypes with healthy controls dogs (n = 10–20). CD3, CD4, CD8, CD25, FoxP3, Ki67, granzyme B, and interferon-γ (IFN-γ) were used to classify T cell subsets in resting and mitogen stimulated PBMCs. In a separate patient cohort (n = 11), T cells were classified using CD3, CD4, CD8, FoxP3, and granzyme B in paired PBMC and single cell suspensions of tumor samples. Analysis of flow cytometric data of individual T cell phenotypes in PBMC revealed specific T cell phenotypes including FoxP3+ and CD25+FoxP3- populations that distinguished patients from healthy controls. Frequencies of IFN-γ+ cells after ConA stimulation identified two different patient phenotypic responses, including a normal/exaggerated IFN-γ response and a lower response suggesting dysfunction. Principle component analysis of selected T cell immunophenotypes also distinguished patients and controls for T cell phenotype and revealed a clustering of patients based on metastasis detected at diagnosis. Findings supported the overall hypothesis that canine melanoma patients display a T cell immunophenotype profile that is unique from healthy pet dogs and will guide future studies designed with larger patient cohorts necessary to further characterize prognostic T cell immunophenotypes.https://www.frontiersin.org/articles/10.3389/fvets.2021.772932/fullmelanomacaninedogimmune profileone healthcomparative oncology
spellingShingle Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
Frontiers in Veterinary Science
melanoma
canine
dog
immune profile
one health
comparative oncology
title T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_full T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_fullStr T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_full_unstemmed T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_short T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_sort t cell immune profiles of blood and tumor in dogs diagnosed with malignant melanoma
topic melanoma
canine
dog
immune profile
one health
comparative oncology
url https://www.frontiersin.org/articles/10.3389/fvets.2021.772932/full
work_keys_str_mv AT ellenesparger tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT hongchang tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT ningchin tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT robertbrebhun tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT sitaswithers tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT hungkieu tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT robertjcanter tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT artammonjazeb tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT michaelskent tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma